3rd Quarter - Report

FEROX STRATEGIES for FRESENIUS KABI USA LLC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare issues related to generic and biosimilar industries.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
ZACHARY BENJAMIN FRIEND New —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Pharmacy PHA

General patent issues related to generic and biosimilar industries.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
ZACHARY BENJAMIN FRIEND New —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

General issues related to trade.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.